Lenka Thieme
Prague, PR, Czech Republic
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Insulin therapy DE-intensificAtion with iGlarLixi: A phase 4, open-label, parallel-group randomised controlled trial.
Journal: Diabetes, obesity & metabolism
Published: August 28, 2025
Metformin Improves Glycemic Control and Postprandial Metabolism and Enhances Postprandial Glucagon-Like Peptide 1 Secretion in Patients With Type 2 Diabetes and Heart Failure: A Randomized, Double-Blind, Placebo-Controlled Trial.
Journal: Clinical diabetes : a publication of the American Diabetes Association
Published: January 20, 2025
Semaglutide Treatment Effects on Liver Fat Content in Obese Subjects with Metabolic-Associated Steatotic Liver Disease (MASLD).
Journal: Journal of clinical medicine
Published: September 02, 2024
The IDEAL (Insulin therapy DE-intensificAtion with iglarLixi) Randomised Controlled Trial-Study Design and Protocol.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: March 08, 2024
A plant-based meal reduces postprandial oxidative and dicarbonyl stress in men with diabetes or obesity compared with an energy- and macronutrient-matched conventional meal in a randomized crossover study.
Journal: Nutrition & metabolism
Published: May 17, 2021
A plant-based meal affects thalamus perfusion differently than an energy- and macronutrient-matched conventional meal in men with type 2 diabetes, overweight/obese, and healthy men: A three-group randomized crossover study.
Journal: Clinical nutrition (Edinburgh, Scotland)
Published: November 22, 2019
A Plant-Based Meal Stimulates Incretin and Insulin Secretion More Than an Energy- and Macronutrient-Matched Standard Meal in Type 2 Diabetes: A Randomized Crossover Study.
Journal: Nutrients
Published: February 04, 2019
Showing 1-9 of 9
Last Updated: 09/26/2026